Joshua A. Kazam
Overview
Joshua A. Kazam received an average of $44K in total compensation at Capricor Therapeutics from 2009 to 2011.
Source: SEC filings on October 10, 2013 and April 8, 2011.
Related executives
We found 15 more executives who work or worked at Capricor Therapeutics.
Linda Marbán
Capricor Therapeutics
Chief Executive Officer
Anthony Bergmann
Capricor Therapeutics
Chief Financial Officer
Karen Krasney
Capricor Therapeutics
General Counsel
Deborah Ascheim
Capricor Therapeutics
Chief Medical Officer
Leland Gershell
Capricor Therapeutics
Chief Financial Officer
Andrew Hamer
Capricor Therapeutics
Vice President of Medical Affairs
Linda Chief
Capricor Therapeutics
Executive Officer
Anthony Davies
Capricor Therapeutics